← Back to Search

Exoskeleton

Hand Exoskeleton for Stroke Rehabilitation

N/A
Waitlist Available
Led By Na Jin Seo, PhD MS BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to move fingers (Chedoke-McMaster Hand Section Stage 2-4)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the 1st half to the 2nd half of the 1-hour training session
Awards & highlights

Study Summary

This trial will develop a new tool to help improve coordination of finger joints, to better address rehabilitation needs and improve hand function for Veterans who have had a stroke.

Who is the study for?
This trial is for adult veterans who had a stroke between 1-6 months ago and can move their fingers somewhat (Chedoke-McMaster Hand Section Stage 2-4). It's not suitable for those who can't follow simple commands or have severe muscle stiffness preventing finger placement, or recent changes in spasticity medication.Check my eligibility
What is being tested?
The SPiRE Maestro Hand Exoskeleton is being tested as a new rehabilitation tool to improve hand function by enhancing finger joint coordination in individuals recovering from a stroke.See study design
What are the potential side effects?
While the trial description does not specify side effects, typical concerns with exoskeleton use may include discomfort at contact points, skin irritation, or fatigue due to training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can move my fingers but with some difficulty.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the 1st half to the 2nd half of the 1-hour training session
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the 1st half to the 2nd half of the 1-hour training session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in finger joint torque assistance

Trial Design

1Treatment groups
Experimental Treatment
Group I: single armExperimental Treatment1 Intervention
All participants will receive assistance to move finger joints away from the compensatory coordination (compensation avoidance), toward the desired trajectories (task assistance), both, and none in different days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exoskeleton
2018
N/A
~70

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,589 Total Patients Enrolled
83 Trials studying Stroke
6,703 Patients Enrolled for Stroke
Na Jin Seo, PhD MS BSPrincipal InvestigatorRalph H. Johnson VA Medical Center, Charleston, SC
2 Previous Clinical Trials
113 Total Patients Enrolled
2 Trials studying Stroke
113 Patients Enrolled for Stroke

Media Library

SPiRE Maestro Hand Exoskeleton (Exoskeleton) Clinical Trial Eligibility Overview. Trial Name: NCT04978467 — N/A
Stroke Research Study Groups: single arm
Stroke Clinical Trial 2023: SPiRE Maestro Hand Exoskeleton Highlights & Side Effects. Trial Name: NCT04978467 — N/A
SPiRE Maestro Hand Exoskeleton (Exoskeleton) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04978467 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for participation in this clinical trial currently?

"According to clinicaltrials.gov, the study is not presently recruiting applicants as it was initially posted on January 2nd 2023 and last updated on July 27th 2022. Nonetheless, there are 1,044 other trials currently enrolling patients."

Answered by AI
~10 spots leftby Sep 2024